GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
Ucap Cloud Information Technology Co.,Ltd
688228
Yangtze Optical Electronic
688143
CN Stock MarketDetailed Quotes
301246 Hubei Hongyuan Pharmaceutical Technology
- 13.14
- +0.09+0.69%
Market Closed Jan 24 15:00 CST
5.26BMarket Cap193.24P/E (TTM)
13.16High12.96Low19.68KlotVolume13.03Open13.05Pre Close25.74MTurnover1.22%Turnover Ratio60.28P/E (Static)400.01MShares23.2452wk High1.21P/B2.11BFloat Cap10.5852wk Low15.66Limit Up160.95MShs Float44.85Historical High10.44Limit Down1.53%Amplitude10.58Historical Low0.05Dividend TTM13.08Avg Price7.81KlotAsk0.38%Div YieldTTM100Lot Size11.63KlotBid
Hubei Hongyuan Pharmaceutical Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -15.17%1.32B | -9.97%898.13M | -15.45%426.06M | -0.43%2.05B | 16.80%1.56B | 10.69%997.63M | 11.69%503.91M | 30.79%2.06B | 25.00%1.33B | 28.99%901.32M |
| Operating revenue | -15.17%1.32B | -9.97%898.13M | -15.45%426.06M | -0.43%2.05B | 16.80%1.56B | 10.69%997.63M | 11.69%503.91M | 30.79%2.06B | 25.00%1.33B | 28.99%901.32M |
| Other operating revenue | ---- | -7.99%12.89M | ---- | 62.88%28.87M | ---- | 233.26%14.01M | ---- | 87.76%17.73M | ---- | -4.64%4.2M |
| Total operating cost | -13.01%1.27B | -8.51%849.87M | -9.77%393.25M | 12.44%1.97B | 30.24%1.46B | 26.46%928.91M | 26.96%435.83M | 43.19%1.75B | 1.12B | 38.84%734.54M |
| Operating cost | -13.14%1.16B | -9.38%772.82M | -11.74%359.02M | 12.99%1.79B | 31.47%1.33B | 29.16%852.82M | 31.83%406.76M | 51.12%1.58B | --1.01B | 48.53%660.26M |
| Operating tax surcharges | -10.95%7.02M | -2.79%4.74M | 39.34%2.35M | 40.65%13.35M | 5.95%7.88M | -15.34%4.87M | -47.95%1.68M | -22.64%9.49M | --7.44M | 13.57%5.76M |
| Operating expense | -4.38%26.48M | 1.76%18.18M | 29.05%8.48M | 3.37%37.69M | 6.41%27.7M | -1.51%17.86M | -14.56%6.57M | -1.48%36.46M | --26.03M | -43.56%18.14M |
| Administration expense | -15.32%34.69M | -8.79%25.69M | 17.07%9.89M | -8.56%60.81M | -10.03%40.96M | -5.93%28.16M | -34.47%8.44M | -6.86%66.5M | --45.53M | 5.60%29.94M |
| Financial expense | 75.66%-547.1K | -69.32%-2.35M | -185.33%-1.66M | 69.04%-3.39M | 83.46%-2.25M | 74.72%-1.39M | 75.39%1.94M | -361.79%-10.96M | ---13.58M | -496.29%-5.48M |
| -Interest expense (Financial expense) | -3.02%8.92M | 11.34%5.9M | 207.12%2.56M | 292.40%13.4M | 316.93%9.2M | 302.85%5.3M | 45.26%832.74K | 43.71%3.41M | --2.21M | 1.05%1.31M |
| -Interest Income (Financial expense) | 21.94%-8.24M | -0.57%-5.67M | -89.47%-2.58M | -731.12%-17.05M | -642.77%-10.56M | -532.99%-5.64M | -621.28%-1.36M | -11.47%-2.05M | ---1.42M | 36.52%-890.55K |
| Research and development | -15.62%41.66M | 15.89%30.79M | 45.49%15.18M | 7.51%68.82M | 26.28%49.37M | 2.49%26.57M | 6.32%10.43M | 31.40%64.01M | --39.1M | 47.31%25.93M |
| Credit Impairment Loss | 71.00%-1.55M | 56.68%-2.12M | -105.94%-135.59K | 25.74%-4.51M | -38.42%-5.34M | -28.49%-4.9M | 282.44%2.28M | -741.78%-6.08M | ---3.86M | -425.99%-3.81M |
| Asset Impairment Loss | -124.72%-23.38M | -36.43%-14.2M | 54.68%-4.72M | 32.63%-26.38M | -57.80%-10.41M | -396.78%-10.41M | -613.76%-10.41M | -241.75%-39.16M | ---6.59M | -833.50%-2.09M |
| Other net revenue | -158.59%-10.82M | -173.17%-6.49M | -69.82%2.35M | -90.22%16.04M | -90.48%18.46M | -94.75%8.87M | -90.79%7.8M | -14.21%164.1M | 193.85M | 210.75%169.04M |
| Fair value change income | -95.92%734.83K | -104.13%-460.37K | --4M | --2.86M | --18M | --11.16M | ---- | ---- | ---- | ---- |
| Invest income | 116.19%1.26M | 146.45%3.01M | -113.62%-849.56K | -88.58%19.42M | -104.63%-7.78M | -104.53%-6.49M | -100.46%-397.69K | -10.65%170M | --167.94M | 178.76%143.06M |
| -Including: Investment income associates | -117.07%-22.79M | -113.05%-14.89M | -663.72%-6.75M | -104.81%-8.14M | -106.25%-10.5M | -104.89%-6.99M | -101.03%-883.79K | -11.08%169.14M | --167.94M | 178.83%143.06M |
| Asset deal income | -77.96%94.5K | -78.98%75.2K | -65.94%75.2K | -96.06%568.54K | -97.03%428.69K | -97.40%357.78K | --220.8K | 307,728.99%14.44M | --14.44M | 293,230.19%13.76M |
| Other revenue | -48.93%12.03M | -62.41%7.2M | -75.27%3.98M | -3.20%24.09M | 7.49%23.55M | 5.63%19.15M | 886.50%16.1M | 88.53%24.88M | --21.91M | 349.49%18.13M |
| Operating profit | -62.59%45.68M | -46.18%41.76M | -53.65%35.17M | -77.99%105.64M | -70.30%122.1M | -76.89%77.6M | -60.60%75.88M | -12.49%479.93M | -0.55%411.1M | 49.88%335.82M |
| Add:Non operating Income | -29.55%88.12K | 54.10%59.64K | 100.91%54.05K | -49.60%156.17K | -38.87%125.07K | -72.94%38.7K | -78.45%26.9K | 453.66%309.86K | --204.62K | 481.76%143.02K |
| Less:Non operating expense | -94.47%400.52K | -74.03%400.51K | 2.31%141.2K | 219.45%7.24M | 178.35%7.24M | -37.45%1.54M | -63.51%138.02K | -34.24%2.27M | --2.6M | 236.84%2.47M |
| Total profit | -60.55%45.37M | -45.57%41.42M | -53.70%35.08M | -79.38%98.56M | -71.87%114.98M | -77.18%76.09M | -60.60%75.76M | -12.30%477.98M | -0.94%408.7M | 49.31%333.5M |
| Less:Income tax cost | -50.63%9.22M | -49.32%5.61M | -64.80%3.88M | -73.62%11.39M | -48.40%18.68M | -64.25%11.07M | -28.93%11.02M | -15.65%43.18M | --36.21M | 22.63%30.96M |
| Net profit | -62.47%36.14M | -44.93%35.81M | -51.81%31.2M | -79.95%87.17M | -74.15%96.3M | -78.51%65.02M | -63.38%64.74M | -11.96%434.8M | -0.58%372.49M | 52.71%302.54M |
| Net profit from continuing operation | -62.47%36.14M | -44.93%35.81M | -51.81%31.2M | -79.95%87.17M | -74.15%96.3M | -78.51%65.02M | -63.38%64.74M | -11.96%434.8M | --372.49M | 52.71%302.54M |
| Net profit of parent company owners | -62.47%36.14M | -44.93%35.81M | -51.81%31.2M | -79.95%87.17M | -74.15%96.3M | -78.51%65.02M | -63.38%64.74M | -11.96%434.8M | -0.58%372.49M | 52.71%302.54M |
| Earning per share | ||||||||||
| Basic earning per share | -63.85%0.0906 | -47.51%0.0897 | -56.50%0.078 | -81.78%0.2246 | -76.27%0.2506 | -78.50%0.1709 | -64.14%0.1793 | -11.96%1.2326 | --1.056 | 41.95%0.7949 |
| Diluted earning per share | -63.85%0.0906 | -47.51%0.0897 | -56.50%0.078 | -81.78%0.2246 | -76.27%0.2506 | -78.50%0.1709 | -64.14%0.1793 | -11.96%1.2326 | --1.056 | 41.95%0.7949 |
| Other composite income | ||||||||||
| Total composite income | -62.47%36.14M | -44.93%35.81M | -51.81%31.2M | -79.95%87.17M | -74.15%96.3M | -78.51%65.02M | -63.38%64.74M | -11.96%434.8M | 372.49M | 52.71%302.54M |
| Total composite income of parent company owners | -62.47%36.14M | -44.93%35.81M | -51.81%31.2M | -79.95%87.17M | -74.15%96.3M | -78.51%65.02M | -63.38%64.74M | -11.96%434.8M | --372.49M | 52.71%302.54M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.